Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remodulin SC Titration in Pulmonary Arterial Hypertension (China)
CTR20160633Phase 4Suspended
- Sponsor
- United Therapeutics Corporation
- Start
- Oct 2016
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of treprostinil in pulmonary arterial hypertension (PAH), sponsored by United Therapeutics Corporation. Started Oct 2016; status: suspended.
02
Drugs
treprostinil
03
Conditions
pulmonary arterial hypertension (PAH)
Beyond the preview
Go deeper on CTR20160633.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20160633.